Latest news:

BioStock-article: The rise of therapeutic peptides: Follicum at the forefront

BioStock published an article on 20 January 2020 about Follicum, which can be read in full below. Pharmaceutical drugs are often subdivided into two fractions: small molecules and large molecules (or biologics). However, a third category called peptides falls right in-between, thus generating an overlap of benefits from the other classes of molecules. Follicum’s two projects, […]

Sign up for our Newsletter

Follicum’s compliance with GDPR. Read more

Hair growth

Our drug candidate FOL-005 has demonstrated increased hair growth on both healthy individuals and on patients with alopecia in two clinical phase II trials, which both demonstrated good safety and efficacy.

Read more


Follicums pre-clinical research has resulted in a new peptide class which increased the release of insulin on mice

Read more


We want to develop safe, effective and cost effective drugs, suitable for both men and women, that have minimal side effects

Read more




04 Feb 20
LSX World Congress

Follicum will attend the LSX World Congress in London, UK, on 4-5 February 2020 The conference...

08 Jun 20
BIO International Convention

Follicum will attend the BIO International Convention in San Diego, USA, on 8-11 June 2020 The confe...